<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wu R</submitter><funding>NIAID NIH HHS</funding><pagination>7958-66</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2990348</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>53(22)</volume><pubmed_abstract>Bioisosteric deaza analogues of 6-methyl-9-?-D-ribofuranosylpurine, a hydrophobic analogue of adenosine, were synthesized and evaluated for antiviral activity. Whereas the 1-deaza and 3-deaza analogues were essentially inactive in plaque assays of infectivity, a novel 7-deaza-6-methyl-9-?-D-ribofuranosylpurine analogue, structurally related to the natural product tubercidin, potently inhibited replication of poliovirus (PV) in HeLa cells (IC(50) = 11 nM) and dengue virus (DENV) in Vero cells (IC(50) = 62 nM). Selectivity against PV over cytotoxic effects to HeLa cells was >100-fold after incubation for 7 h. Mechanistic studies of the 5'-triphosphate of 7-deaza-6-methyl-9-?-D-ribofuranosylpurine revealed that this compound is an efficient substrate of PV RNA-dependent RNA polymerase (RdRP) and is incorporated into RNA mimicking both ATP and GTP.</pubmed_abstract><journal>Journal of medicinal chemistry</journal><pubmed_title>Synthesis of a 6-methyl-7-deaza analogue of adenosine that potently inhibits replication of polio and dengue viruses.</pubmed_title><pmcid>PMC2990348</pmcid><funding_grant_id>AI054776</funding_grant_id><funding_grant_id>U01 AI054776</funding_grant_id><funding_grant_id>U01 AI082068-01</funding_grant_id><funding_grant_id>U01 AI054776-05</funding_grant_id><funding_grant_id>R01 AI070791</funding_grant_id><funding_grant_id>R01 AI045818</funding_grant_id><funding_grant_id>AI070791</funding_grant_id><funding_grant_id>AI082068</funding_grant_id><funding_grant_id>U01 AI082068</funding_grant_id><funding_grant_id>R01 AI070791-01</funding_grant_id><pubmed_authors>Cameron CE</pubmed_authors><pubmed_authors>Padmanabhan R</pubmed_authors><pubmed_authors>Peterson BR</pubmed_authors><pubmed_authors>Wu R</pubmed_authors><pubmed_authors>Smidansky ED</pubmed_authors><pubmed_authors>Oh HS</pubmed_authors><pubmed_authors>Takhampunya R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Synthesis of a 6-methyl-7-deaza analogue of adenosine that potently inhibits replication of polio and dengue viruses.</name><description>Bioisosteric deaza analogues of 6-methyl-9-?-D-ribofuranosylpurine, a hydrophobic analogue of adenosine, were synthesized and evaluated for antiviral activity. Whereas the 1-deaza and 3-deaza analogues were essentially inactive in plaque assays of infectivity, a novel 7-deaza-6-methyl-9-?-D-ribofuranosylpurine analogue, structurally related to the natural product tubercidin, potently inhibited replication of poliovirus (PV) in HeLa cells (IC(50) = 11 nM) and dengue virus (DENV) in Vero cells (IC(50) = 62 nM). Selectivity against PV over cytotoxic effects to HeLa cells was >100-fold after incubation for 7 h. Mechanistic studies of the 5'-triphosphate of 7-deaza-6-methyl-9-?-D-ribofuranosylpurine revealed that this compound is an efficient substrate of PV RNA-dependent RNA polymerase (RdRP) and is incorporated into RNA mimicking both ATP and GTP.</description><dates><release>2010-01-01T00:00:00Z</release><publication>2010 Nov</publication><modification>2020-10-31T08:20:47Z</modification><creation>2019-03-27T00:36:50Z</creation></dates><accession>S-EPMC2990348</accession><cross_references><pubmed>20964406</pubmed><doi>10.1021/jm100593s</doi></cross_references></HashMap>